Coronary Artery Disease and Myocardial Infarction

TCT 22: FAME 3: FFR-Guided PCI Vs CABG in Pts With Multivessel CAD

Yuhei Kobayashi,

Watch time: 07:21
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2:56
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3:24
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3:00
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3:22
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Dinakar Bootla , Pruthvi C Revaiah , Navjyot Kaur , et al

EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx

Giuseppe Tarantini,

Yoshiyasu Minami , Daisuke Kinoshita , Yusuke Muramatsu , et al

4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

Erin D Michos,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
Secondary Analysis of CANTOS Finds LDL & HDL Predict Residual Risk of Atherosclerotic Events

Paul M Ridker,

Heather Currie , Christine Williams ,

, Carlo Savini , Marco Di Eusanio ,

Edward T Carreras , Donna M Polk ,

Sivabaskari Pasupathy , Rosanna Tavella , Simon McRae , et al

Hans-Willi Breuer ,

FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2:56

Remo Albiero ,

Astrid Hubert , Andreas Seitz , Valeria Martínez Pereyra , et al

FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3:00

Kevin Cheng , Paul Sainsbury , Michael Fisher , et al

Kamal Chitkara , Anthony H Gershlick ,

Rajiv Rampat , David Hildick-Smith ,

Media

FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2:56
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3:24
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3:00
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Yassir Javaid, Nina Barnett, Paresh Parmar, et al

Prof Lale Tokgozoglu, Kausik (Kosh) Ray, Maciej Banach, et al

Paul M Ridker, Aernoud Fiolet, Jean-Claude Tardif, et al

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
ACC 2022 Late-breaker Discussion: The SuperWIN Trial

Dylan L Steen, Harriette Van Spall,

UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen, et al

Barbara Stähli , Stephan Kische, Tommaso Gori, et al

Guy Van Camp, Koen Van Bockstal, Enrico Neri, et al

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

ACC 2021: Findings From the RESCUE Trial

Paul M Ridker,

AHA 2020: Findings from the THALES trial — Prof Pierre Amarenco

Pierre Amarenco,

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, Connie N Hess,

ESC 2020: Final Results of the EVAPORATE Trial

Matthew J Budoff,

ACC 2020 Wrap Up: An Analysis of the Late-breaking Trials

Joost Daemen, Nicolas M Van Mieghem,

ESC 2015 : Ethnic Differences in Incidences of Coronary Artery Spasm

Hiroaki Shimokawa,

Media

TCT 22: FAME 3: FFR-Guided PCI Vs CABG in Pts With Multivessel CAD

Yuhei Kobayashi,

Watch time: 07:21
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2:56
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3:24
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3:00
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3:22
ESC 22: ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease

Isla Mackenzie,

Watch time: 2:27

Yassir Javaid, Nina Barnett, Paresh Parmar, et al

Prof Lale Tokgozoglu, Kausik (Kosh) Ray, Maciej Banach, et al

EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx

Giuseppe Tarantini,

4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

Erin D Michos,

Paul M Ridker, Aernoud Fiolet, Jean-Claude Tardif, et al

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
Secondary Analysis of CANTOS Finds LDL & HDL Predict Residual Risk of Atherosclerotic Events

Paul M Ridker,

ACC 22: PACMAN-AMI Shows Reduced Plaque Regression in AMI Patients Treated with Alirocumab

Lorenz Räber,

ACC 22: Magnitude & Duration of Effects of a siRNA Targeting Lp(a)

Steven E Nissen,

ACC 22: Results from the TRANSLATE-TIMI 70 Trial

Brian Bergmark,

ACC 22: FAME 3 Suggests CABG Outperforms FFR-Guided PCI in Patients with Multivessel Disease

Frederik Zimmermann,

ACC 2022 Late-breaker Discussion: The SuperWIN Trial

Dylan L Steen, Harriette Van Spall,

UZ Clear Finds 50% Patients with Angina Have Evidence of CAD

Carlos Collet,

EP 63: Innovation, Research, and the Concept of Hemorrhagic MI with Dr Rohan Dharmakumar

Ankur Kalra, Rohan Dharmakumar,

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen, et al

Transcontinental CHIP Case Sharing Club: CHIP with or without MCS (Mechanical Circulatory Support)

Kevin J. Croce, Eric Eeckhout, Chui Ka-Lung, et al

Barbara Stähli , Stephan Kische, Tommaso Gori, et al

Guy Van Camp, Koen Van Bockstal, Enrico Neri, et al

RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes

Nick Curzen,

EuroPCR 21: The EBC Main Study

David Hildick-Smith,

ACC 2021: Findings From the RESCUE Trial

Paul M Ridker,

ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall,

What to Expect at TCTAP 2021

Bill D Gogas, Duk-Woo Park,

Carlos Aguiar, Maciej Banach, , et al

Articles

Rotatripsy in Left Main Disease

Dinakar Bootla

,

Pruthvi C Revaiah

,

Navjyot Kaur

,

Yash Paul Sharma

,

Himanshu Gupta

,

Published:

25 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e13.

DOI:

https://doi.org/10.15420/japsc.2021.24
  • Views: Views 414
  • Downloads: Downloads 23

Lipoprotein(a) and Cardiovascular Disease

Yoshiyasu Minami

,

Daisuke Kinoshita

,

Yusuke Muramatsu

,

Takako Nagata

,

Junya Ako

,

Published:

13 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e11.

DOI:

https://doi.org/10.15420/japsc.2021.31
  • Views: Views 552
  • Downloads: Downloads 43

Prevalence of CYP2C19 Gene Polymorphism in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Maya Rosana Amalia

,

Susi Herminingsih

,

Published:

14 December 2021

Citation:

European Cardiology Review 2021;16:e61.

DOI:

https://doi.org/10.15420/ecr.2021.16.PO5
  • Views: Views 256
  • Downloads: Downloads 12

APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh

,

Brian Ference

,

Stephen J Nicholls

,

Ann Marie Navar

,

Derek P Chew

,

Karam M Kostner

,

Ben He

,

Hung-Fat Tse

,

Jamshed J Dalal

,

Anwar Santoso

,

Junya Ako

,

Hayato Tada

,

Jin Joo Park

,

Mei Lin Ong

,

Eric Lim

,

Tavin Subramaniam

,

Yi-Heng Li

,

Arintaya Phrommintikul

,

SS Iyengar

,

Saumitra Ray

,

Kyung Woo Park

,

Hong Chang Tan

,

Narathip Chunhamaneewat

,

Khung Keong Yeo

,

Jack Wei Chieh Tan

,

Published:

09 December 2021

Citation:

European Cardiology Review 2021;16:e54.

DOI:

https://doi.org/10.15420/ecr.2021.36
  • Views: Views 1038
  • Downloads: Downloads 102